Belatacept Clinical Trials
8 recruitingDrug
Phase 24Phase 31Phase 11Phase 41
Showing 1–8 of 8 trials
Recruiting
Phase 4
Comparison of the Effects of Belatacept and Anticalcineurins on Endothelial Function in Renal Transplant Patients - <BELAFENDO>
Kidney Diseases
University Hospital, Rouen44 enrolled1 locationNCT06291077
Recruiting
Phase 1
Treatment of Antibody-Mediated Rejection (ABMR) With CarBel
Kidney Transplant Rejection
National Institute of Allergy and Infectious Diseases (NIAID)25 enrolled10 locationsNCT06918990
Recruiting
Phase 2
Advancing Transplantation Outcomes in Children
Kidney Transplant
National Institute of Allergy and Infectious Diseases (NIAID)200 enrolled20 locationsNCT06055608
Recruiting
Phase 2
Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy
Immunosuppression
Linda Cendales50 enrolled1 locationNCT02310867
Recruiting
Phase 2
Belatacept in Heart Transplantation
Heart Transplant
National Institute of Allergy and Infectious Diseases (NIAID)66 enrolled5 locationsNCT06478017
Recruiting
Phase 3
A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications
Renal Allograft Recipients
Bristol-Myers Squibb102 enrolled38 locationsNCT04877288
Recruiting
Phase 2
Belatacept in De Novo Heart Transplantation
Heart Transplantation
NYU Langone Health12 enrolled2 locationsNCT04477629
Recruiting
Evolution of CMV Antiviral T-cell Immunity Over the Next Six Months Initiation of Treatment With Belatacept.
Kidney Transplant Infection
University Hospital, Rouen28 enrolled1 locationNCT05708534